Foghorn Therapeutics Inc. Quarterly Nonoperating Income (Expense) in USD from Q3 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Foghorn Therapeutics Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q3 2019 to Q3 2024.
  • Foghorn Therapeutics Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $4.73M, a 36.2% increase year-over-year.
  • Foghorn Therapeutics Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $14.9M, a 11.5% increase year-over-year.
  • Foghorn Therapeutics Inc. annual Nonoperating Income (Expense) for 2023 was $13.7M, a 66% increase from 2022.
  • Foghorn Therapeutics Inc. annual Nonoperating Income (Expense) for 2022 was $8.26M.
  • Foghorn Therapeutics Inc. annual Nonoperating Income (Expense) for 2021 was -$586K, a 118% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $14.9M $4.73M +$1.26M +36.2% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-04
Q2 2024 $13.6M $3.65M +$148K +4.22% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $13.5M $3.18M -$211K -6.23% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $13.7M $3.34M +$338K +11.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-07
Q3 2023 $13.4M $3.47M +$984K +39.5% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-04
Q2 2023 $12.4M $3.51M +$1.63M +86.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $10.8M $3.39M +$2.5M +281% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q4 2022 $8.26M $3M +$4.06M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-07
Q3 2022 $4.19M $2.49M +$2.31M +1276% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $1.89M $1.88M +$1.73M +1150% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 $160K $890K +$746K +518% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 -$586K -$1.06M -$1.08M -5152% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-09
Q3 2021 $496K $181K +$59K +48.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $437K $150K +$334K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $103K $144K +$372K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 -$269K $21K Oct 1, 2020 Dec 31, 2020 10-K/A 2022-08-09
Q3 2020 $122K +$114K +1425% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$184K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 -$228K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q3 2019 $8K Jul 1, 2019 Sep 30, 2019 10-Q 2020-12-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.